Skip to main content
. 2022 Nov 3;36(6):2852–2860. doi: 10.21873/invivo.13025

Table IV. Univariate and multivariate analyses of preoperative factors for recurrence-free survival.

graphic file with name in_vivo-36-2856-i0001.jpg

CEA: Carcinoembryonic antigen; CI: confidence interval; CR: complete response; DCF: docetaxel, cisplatin, and 5-fluorouracil; ECOG PS: Eastern Cooperative Oncology Group performance score; EGJ: esophagogastric junction; HR: hazard ratio; L: lower third; LNM: lymph node metastasis; M: middle third; PD: progressive disease; PR: partial response; RECIST: Response Evaluation Criteria in Solid Tumors: SCC-A: squamous cell carcinoma-related antigen; SD: stable disease; U: upper third. aTNM classification, 8th edition (7). bClavien-Dindo classification. cResponse evaluation criteria of Japan Esophageal Society (11). Statistically significant p-values are shown in bold.